Factor VIII Antibody (GMA-8002): sc-65949

Factor VIII Antibody (GMA-8002) is a mouse monoclonal IgG2a antibody designed to target the A1 domain of B domain-deleted recombinant human Factor VIII, also known as anti-hemophilic factor or von Willebrand factor-binding protein. Factor VIII is a crucial glycoprotein cofactor in the intrinsic pathway of the blood coagulation cascade, playing a vital role in the activation of Factor X to Factor Xa, which ultimately leads to the formation of stable blood clots. Anti-Factor VIII antibody (GMA-8002) effectively detects human Factor VIII through enzyme-linked immunosorbent assay (ELISA) assays, ensuring reliable performance for both research and diagnostic applications. Factor VIII interacts with key proteins such as von Willebrand factor (VWF), which stabilizes Factor VIII in the bloodstream, and forms complexes with Factor IXa during the coagulation process, highlighting Factor VIII′s central role in maintaining hemostasis. The precise targeting of the A1 domain by Factor VIII monoclonal antibody (GMA-8002) allows for detailed studies on Factor VIII′s function and interactions with other coagulation factors, which is essential for understanding and treating hemophilia A, a severe hereditary bleeding disorder caused by deficiencies or dysfunctions of Factor VIII. Additionally, Factor VIII undergoes important post-translational modifications, including glycosylation, which are critical for Factor VIII′s stability and activity, making accurate detection of functional domains imperative for therapeutic developments. Factor VIII (GMA-8002) antibody facilitates accurate measurement and analysis of Factor VIII, supporting the advancement of targeted therapies and improving diagnostic assays aimed at enhancing patient outcomes. Factor VIII (GMA-8002) monoclonal antibody is an indispensable tool for laboratories focused on hemostasis, blood coagulation research, and the development of treatments for Factor VIII-related disorders. Anti-Factor VIII antibody (GMA-8002) provides researchers and clinicians with a robust and reliable means to investigate the essential functions of Factor VIII, contributing to significant advancements in the understanding and management of coagulation disorders.

The preferred Factor VIII antibody is Factor VIII Antibody (R8B12): sc-73597.